NT-proBNP and echocardiographic markers for LV diastolic dysfunction and LV remodelling are of prognostic value in patients with BAV for arrhythmia- and intervention-free survival and should have a more prominent role in clinical practice. The gene discussed is NPPB; the disease is cardiac arrhythmia.